Clinical Trial Update: A Study of FCN-338 in Patients With Chronic CLL/SLL [Phase 1]

View source ↗

Summary

FCN-338 is being evaluated in a Phase 1 trial for chronic lymphocytic leukemia and small lymphocytic lymphoma, with the study currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• FCN-338

Snippet

Sponsor: Fochon Pharmaceuticals, Ltd. | Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING